LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $22,978 | $14,979 | $21,404 |
| Short-Term Investments | $5,021 | $28,312 | $0 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $880 | $2,343 | $85 |
| Total Curr. Assets | $28,879 | $45,634 | $21,489 |
| Property Plant & Equip (Net) | $4,157 | $23 | $3 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $498 | $0 | $0 |
| Total NC Assets | $4,655 | $23 | $3 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $33,534 | $45,657 | $21,492 |
| Liabilities | – | – | – |
| Payables | $2,320 | $1,389 | $156 |
| Short-Term Debt | $487 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $5,302 | $1,217 | $313 |
| Total Curr. Liab. | $8,109 | $2,606 | $469 |
| LT Debt | $3,216 | $0 | $24,148 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $116,763 | $77,524 | $25,687 |
| Total NC Liab. | $119,979 | $77,524 | $49,835 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $3,703 | $0 | $0 |
| Total Liabilities | $128,088 | $80,130 | $50,304 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 |
| Retained Earnings | -$104,323 | -$41,221 | -$34,946 |
| AOCI | $111 | $274 | $0 |
| Other Equity | $9,657 | $6,473 | $6,133 |
| Total Equity | -$94,554 | -$34,473 | -$28,812 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $33,534 | $45,657 | $21,492 |
| Net Debt | -$19,275 | -$14,979 | $2,744 |